Not all clients with CLL call for therapy. Regardless of all the latest improvements, the iwCLL still suggests watchful observation for patients with asymptomatic disorder.86 This recommendation relies on at the very least two randomized trials comparing observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR). Klik tombol https://helena197ajr5.blgwiki.com/user